CARDIFF ONCOLOGY INC (CRDF) Stock Balance Sheet
NASDAQ:CRDF - Nasdaq - US14147L1089 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.04M | 21.66M | 16.30M | 11.90M | 131.00M | |||
| Marketable Securities | 44.63M | 53.17M | 88.90M | 128.90M | N/A | |||
| Receivables | 618.00K | 888.00K | 800.00K | 500.00K | 300.00K | |||
| Other Current Assets | 1.05M | 1.70M | 5.20M | 4.80M | 2.10M | |||
| Total Current Assets | 59.33M | 77.41M | 111.30M | 146.10M | 133.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.30M | 2.95M | 3.50M | 3.20M | 1.00M | |||
| Other Non-Current Assets | 1.27M | 1.28M | 1.40M | 200.00K | 400.00K | |||
| Total Non-Current Assets | 3.56M | 4.22M | 4.90M | 3.40M | 1.30M | |||
| TOTAL ASSETS | 62.90M | 81.64M | 116.20M | 149.50M | 134.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 7.88M | 8.47M | 5.70M | 4.50M | 4.20M | |||
| Accounts Payable | 4.64M | 1.97M | 2.00M | 1.40M | 1.40M | |||
| Other Current Liabilities | N/A | N/A | 100.00K | 600.00K | 500.00K | |||
| Total Current Liabilities | 12.53M | 10.44M | 7.80M | 6.60M | 6.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 979.00K | 1.46M | 2.00M | 2.60M | 500.00K | |||
| Total Non-Current Liabilities | 979.00K | 1.46M | 2.00M | 2.50M | 500.00K | |||
| TOTAL LIABILITIES | 13.50M | 11.90M | 9.80M | 9.10M | 6.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -372.39M | -339.54M | -298.10M | -259.80M | -231.50M | |||
| Additional Paid In Capital | 421.70M | 409.34M | 404.80M | 400.50M | 361.80M | |||
| Common Shares | 5.00K | 4.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 82.00K | -67.00K | -400.00K | -300.00K | -2.20M | |||
| Shares Outstanding | 48.73M | 44.68M | 44.70M | 42.00M | 36.80M | |||
| Tangible Book Value per Share | 1.01 | 1.56 | 2.38 | 3.34 | 3.48 | |||
| Total Shareholders' Equity | 49.39M | 69.74M | 106.30M | 140.40M | 128.20M | |||
| TOTAL LIABILITIES AND EQUITY | 62.90M | 81.64M | 116.20M | 149.50M | 134.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.74 | 7.41 | 14.27 | 22.14 | 21.87 | |||
| Return On Assets (ROA) | -68.37% | -50.79% | -33.33% | -18.94% | -16.78% | |||
| Return On Equity (ROE) | -87.07% | -59.46% | -36.43% | -20.17% | -17.63% | |||
All data in USD , ROIC based on taxRate of 0.21